The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Genomic landscape of angiosarcoma: A targeted and immunotherapy biomarker analysis of 143 patients.
 
Andrea P. Espejo Freire
No Relationships to Disclose
 
Andrew Elliott
Employment - Caris Life Sciences
 
Yamac Akgun
No Relationships to Disclose
 
Philippos Costa
No Relationships to Disclose
 
Maryam Alasfour
No Relationships to Disclose
 
Andrew Rosenberg
No Relationships to Disclose
 
Julio Diaz-Perez
No Relationships to Disclose
 
Ty Subhawong
No Relationships to Disclose
 
Junaid Arshad
No Relationships to Disclose
 
Wolfgang Michael Korn
Employment - Caris Life Sciences
Leadership - Caris Life Sciences
Consulting or Advisory Role - Merck Sharp & Dohme
Travel, Accommodations, Expenses - Merck Sharp & Dohme
 
Don S. Dizon
Stock and Other Ownership Interests - InfiniteMD; NeuHope
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; i-Mab; Regeneron; Tesaro
Research Funding - Bristol-Myers Squibb (Inst); Kazia Therapeutics (Inst); Merck Sharp & Dohme (Inst); Tesaro (Inst)
 
Margaret von Mehren
Honoraria - Pfizer
Consulting or Advisory Role - deciphera; Exelixis
Research Funding - ADCO (Inst); Arog (Inst); ArQule; Blueprint Medicines (Inst); Deciphera (Inst); Genmab (Inst); Gradalis (Inst); Lilly (Inst); Novartis (Inst); Springworks Therapeutics (Inst)
Travel, Accommodations, Expenses - Deciphera; Deciphera; NCCN
Other Relationship - NCCN
 
Moh'd M. Khushman
Stock and Other Ownership Interests - Aprea therapeutics; Blueprint Medicines; Daiichi Sankyo; Global Blood Therapeutics; Guardant Health; Halozyme
Speakers' Bureau - AstraZeneca
 
Atif Mahmoud Hussein
Research Funding - Genentech/Roche (Inst); Janssen (Inst); Sellas Life Sciences (Inst)
 
Kirsten Leu
Consulting or Advisory Role - Epizyme; Immune Design
 
Jonathan C. Trent
Honoraria - GlaxoSmithKline
Consulting or Advisory Role - Blueprint Medicines; Daiichi Sankyo; Deciphera; Epizyme; Janssen; Lilly; Novartis